AI Article Synopsis

  • Previous research identified increased TXNIP gene expression in the placentas of patients with gestational diabetes mellitus (GDM), but the reasons for this remain unknown, prompting further investigation.
  • This study used a Tet-On "switch" to artificially enhance TXNIP levels in human placental cells, facilitating examination of how these changes affected cell behavior.
  • Results showed that higher TXNIP levels in GDM placentas led to increased cell migration and invasion without affecting apoptosis or proliferation, suggesting that TXNIP might disrupt normal placental functions in GDM through specific pathways involving STAT3 and Vimentin.

Article Abstract

Introduction: Our previous study has proofed the glucose sensitive gene-thioredoxin-interacting protein (TXNIP) expression was up in the placenta of the patients with gestational diabetes mellitus (GDM), but the pathological mechanisms underlying abnormal TXNIP expression in the placenta of patients with GDM is completely unclear and additional investigations are required to explain the findings we have observed. In the present study, we simulated the high TXNIP expression via introducing the Tet-On "switch" in vitro, approximate to its expression level in the real world, to explore the following consequence of the abnormal TXNIP.

Methods: The expression and localization of TXNIP in the placenta of GDM patients and the health control was investigated via immunofluorescent staining, western blot and RT-qPCR. Overexpression of TXNIP was achieved through transfecting Tet-on system to the human trophoblastic cell line-HTR-8/Svneo cell. TXNIP knockout was obtained via CRISPR-Cas9 method. The cell phenotype was observed via IncuCyte Imaging System and flow cytometry. The mechanism was explored via western blot and RT-qPCR.

Results: The expression level of TXNIP in the GDM placenta was nearly 2-3 times higher than that in the control. The TXNIP located at trophoblastic cells of the placenta. When the expression of TXNIP was upregulated, the migration and invasion of the cells accelerated, but cell apoptosis and proliferation did not changed compared with the control group. Furthermore, the size of the TetTXNIP cells became larger, and the expression level of Vimentin and p-STAT3 increased in the TetTXNIP cells. All the changes mentioned above were opposite in the TXNIP-KO cells.

Conclusions: Abnormal expression of TXNIP might be related to the impairment of the GDM placental function, affecting the migration and invasion of the placental trophoblast cells through STAT3 and Vimentin related pathway; thus, TXNIP might be the potential therapeutic target for repairing the placental dysfunction deficient in GDM patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084645PMC
http://dx.doi.org/10.1186/s12884-023-05524-6DOI Listing

Publication Analysis

Top Keywords

txnip expression
16
migration invasion
12
expression level
12
txnip
11
expression
10
high txnip
8
gdm placenta
8
expression placenta
8
placenta patients
8
gdm patients
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!